SCHEMBL29638666

SCHEMBL29638666

Cc1ccc2c(Nc3cc(Cl)ccc3F)nccc2c1N1CN=C(N)c2cc(F)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.34
PIM1 P11309 1/20 0.34
FLT3 P36888 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
BRAF P15056 4/20 0.33
LCK P06239 3/20 0.33
ABL1 P00519 1/20 0.33
AGPAT2 O15120 1/20 0.33
ADORA2A P29274 1/20 0.33
GRM4 Q14833 1/20 0.32
EGFR P00533 2/20 0.32
RAF1 P04049 1/20 0.32
CSF1R P07333 1/20 0.32
DDR1 Q08345 1/20 0.32
DDR2 Q16832 1/20 0.32
KDR P35968 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638518 0.90 FGFR1 (0.36) MAPK1PIM1FLT3PIM3PIM2
SCHEMBL29638578 0.86 RAF1 (0.43) BRAFGRM4EGFRRAF1CSF1R
SCHEMBL29638706 0.78 RAF1 (0.45) BRAFEGFRRAF1CSF1RDDR1
SCHEMBL29638669 0.78 TNNI3K (0.35) PIM1PIM2KDR
SCHEMBL29638490 0.77 MAPK14 (0.31) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638629 0.77 RAF1 (0.41) BRAFEGFRRAF1CSF1RDDR1
SCHEMBL24399614 0.75 ADORA2A (0.46) PIM1FLT3PIM3PIM2BRAF
SCHEMBL29638645 0.75 BRAF (0.33) BRAFLCKRAF1CSF1RDDR1
SCHEMBL29638581 0.74 RAF1 (0.43) PIM1PIM2BRAFGRM4EGFR
SCHEMBL24399762 0.72 DHFR (0.40) PIM1PIM2BRAFLCKADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed